“Heart failure at either end of the spectrum”

It's been a little over a year since the new and improved guidelines for the management of heart failure were released.1 Significant changes in the treatment of both acute and chronic heart failure have occurred since 2017 when the last updates were released.2 Guideline directed medical therapy now includes four medication classes. New recommendations for heart failure with preserved ejection fraction now include the use of SGLT2i, MRAs and ARNi. Amyloid heart disease has been included, as well as recommendations for those patients whose left ventricular ejection fraction has improved to>40%.
Source: Heart and Lung - Category: Intensive Care Authors: Tags: Editorial Source Type: research